Qube Research & Technologies LTD Harmony Biosciences Holdings, Inc. Transaction History

Qube Research & Technologies LTD

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$28.81 - $33.01 $150,445 - $172,378	-5,222 Reduced 42.01%	7,209 $217,000
Q1 2024 May 14, 2024	SELL	$29.93 - $35.06 $816,849 - $956,857	-27,292 Reduced 68.71%	12,431 $417,000
Q4 2023 Feb 13, 2024	BUY	$19.2 - $33.78 $751,987 - $1.32 Million	39,166 Added 7031.6%	39,723 $1.28 Million
Q3 2023 Nov 13, 2023	BUY	$31.89 - $39.03 $17,762 - $21,739	557 New	557 $18,000
Q4 2022 Feb 14, 2023	BUY	$45.4 - $60.91 $2.31 Million - $3.09 Million	50,779 New	50,779 $2.8 Million
Q2 2022 Aug 15, 2022	SELL	$33.54 - $52.15 $765,718 - $1.19 Million	-22,830 Closed	0 $0
Q1 2022 May 09, 2022	BUY	$33.14 - $51.13 $756,586 - $1.17 Million	22,830 New	22,830 $1.11 Million
Q1 2021 May 14, 2021	SELL	$27.56 - $40.37 $360,264 - $527,716	-13,072 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$31.74 - $51.34 $205,199 - $331,913	6,465 Added 97.85%	13,072 $473,000
Q3 2020 Nov 12, 2020	BUY	$30.96 - $44.39 $204,552 - $293,284	6,607 New	6,607 $224,000

242

45.1M

108K

49.2K

Ticker HRMY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,161,400
Market Cap $2.02B
Description
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.